Current Knowledge on Graves’ Orbitopathy
(1) Background: Graves’ orbitopathy (GO) is an autoimmune inflammation of the orbital tissues and the most common extra-thyroid symptom of Graves’ disease (GD). Mild cases of GO are often misdiagnosed, which prolongs the diagnostic and therapeutic process, leading to exacerbation of the disease. A s...
Main Authors: | Katarzyna Gontarz-Nowak, Magdalena Szychlińska, Wojciech Matuszewski, Magdalena Stefanowicz-Rutkowska, Elżbieta Bandurska-Stankiewicz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/1/16 |
Similar Items
-
Puls-therapy with metilprednisolon in Grave's orbitopathy
Published: (2012-12-01) -
Graves' orbitopathy treated with immunosuppressive therapy and orbital radiotherapy in a tertiary care endocrine centre: case series
by: D. C. Kottahachchi, et al.
Published: (2016-08-01) -
Factors associated with severity of orbitopathy in patients with Graves' disease
by: Tauseef Nabi, et al.
Published: (2020-01-01) -
Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves’ orbitopathy
by: Dorota Walasik-Szemplińska, et al.
Published: (2019-12-01) -
Treatment with Intravenous Methylprednisolone in Patients with Graves’ Orbitopathy Significantly Affects Adrenal Function: Assessment of Serum, Salivary Cortisol and Serum Dehydroepiandrosterone Sulfate
by: Katarzyna Pelewicz, et al.
Published: (2020-10-01)